Oxford Biomedica Plc

Vulpes Investment Management is a long-term investor which aims to generate real capital appreciation and income through concentration on a small number of compelling investment opportunities. The firm’s investment focus is Agriculture and German Real Estate. For long-term capital growth, Vulpes Investment Management invests across Life Sciences, Disruptive Technologies and other Private Equity style opportunities.

LIL’s investment process includes the objective, strategy, implementation and review. The firm’s fund management teams use distinct and rigorous investment process in managing their funds. They invest worldwide and manage generalist, diversified portfolios spread across various sectors, managed both on a global and regional basis. LIL’s investment team seeks to create value for shareholders over the medium- to long-term, utilizing a top-down approach for asset allocation and a bottom-up approach for selecting ordinary shares. They monitor performance against relevant indexes, but do not track any index. The firm is primarily an equity investor.

CGWL is an active, long-term investor which offers clients an access to a wide range of portfolio building and management resources, supported by rigorous, robust and highly analytical investment process includes in-depth research, in-house resources and insights into local and international markets. The firm’s discretionary portfolios invest in individual stocks and bonds, and other alternative asset classes. They also invest in third party investment funds, for added diversification and access to a wide range of investment styles and strategies. CGWL provides a range of different investments, including securities, equities, funds, exchange-traded funds (ETFs), investment trusts, venture capital trusts (VCTs), enterprise investment schemes (EISs), alternatives, bonds and cash.